Univ.-Prof. Dr. Gerald Gartlehner, MPH
Head of Department - Department for Evidence-based Medicine and Evaluation
- gerald.gartlehner@donau-uni.ac.at
- +43 2732 893-2910
- +43 664 81 53 565
- +43 2732 893-4910 (Fax)
- To contact form
- Campus Krems, Tract X, 1st Floor, 009
- Donau-Universität Krems
- Department for Evidence-based Medicine and Evaluation
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Austria
Projects (Extract Research Database)
Rapid Reviews - Single Screening RCT classifier
Systematischer Review Point of Care Ultrasound
Erstellung einer systematischen Literatursuche für das österreichische Hebammengremium
Drug Effectiveness Review Project/Cooperation RTI
Wirkt Weiterbildung präventiv gegen Demenzentwicklung?
Second - Generation Antidepressants: Stand - alone report
Publications (Extract Research Database)
Gartlehner, G.; Affengruber, L.; Titscher, V.; Noel-Storr, A.; Dooley, G.; Ballarini, N.; König, F. (2020). Single-reviewer abstract screening missed 13 percent of relevant studies:a crowd-based, randomized controlled trial. Journal of Clinical Epidemiology, 121: 20-28
Nussbaumer-Streit, B.; Klerings, I.; Dobrescu, A.I.; Persad, E.; Stevens, A.; Garritty, C.; Kamel, C.; Affengruber, L.; King, V.J.; Gartlehner, G. (2020). Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study. Journal of Clinical Epidemiology, 118: 42-54
Morche, J.; Freitag, S.; Hoffmann, F.; Rissling, O.; Langer, G.; Nussbaumer-Streit, B.; Toews, I.; Gartlehner, G.; Meerpohl, J.J. (2020). GRADE-Leitlinien: 18. Wie ROBINS-I und andere Instrumente zur Einschätzung des Risikos für Bias von nicht-randomisierten Studien verwendet werden sollten, um die Vertrauenswürdigkeit eines Evidenzkörpers zu bewerten. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, in press: in press
Christof, C.; Nussbaumer-Streit, B.; Gartlehner, G. (2019). Risikokommunikation in gesundheitsbedrohlichen Krisensituationen: Zusammenfassung einer WHO-Leitlinie. Gesundheitswesen, 81(10): 846-849
Donahue, K.E.; Schulman, E.R.; Gartlehner, G.; Jonas, B.L.; Coker-Schwimmer, E.; Patel, S.V.; Palmieri Weber, R.; Bann, C.M.; Viswanathan, M. (2019). Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis. J Gen Intern Med, Epub ahead of print: doi: 10.1007/s11606-019-05230-0.
Forneris, C.A.; Nussbaumer-Streit, B.; Morgan, L.C.; Greenblatt, A.; Van Noord M.G.; Gaynes, B.N.; Wipplinger, J.; Lux, L.J.; Winkler, D.; Gartlehner, G. (2019). Psychological therapies for preventing seasonal affective disorder (Review). Cochrane Database of Systematic Reviews, Issue 5: Art. No.: CD011270.
Gartlehner, G.; Nussbaumer-Streit, B.; Gaynes, B. N.; Forneris, C. A.; Morgan, L. C.; Greenblatt, A.; Wipplinger, J.; Lux, L. J.; Van Noord, M. G.; Winkler, D. (2019). Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database Syst Rev, 3: 10.1002/14651858.CD011268.pub3
Gartlehner, G.; Nußbaumer-Streit, B.; Wagner, G.; Patel, S.; Swinson-Evans, T.; Dobrescu, A; Gluud, C.; (2019). Increased risks for random errors are common in outcomes graded as high certainty of evidence. Journal of Clinical Epidemiology, 106: 50-59
Gartlehner, G.; Wagner, G.; Lux, L.; Affengruber, L.; Dobrescu, A.; Kaminski-Hartenthaler, A.; Viswanathan, M. (2019). Assessing the accuracy of machine-assisted abstract screening with DistillerAI: a user study. Systematic Reviews, 8:277: https://doi.org/10.1186/s13643-019-1221-3
Gaynes, B.N.; Lux, L.; Gartlehner, G.; Asher, G.; Forman-Hoffman; V.; Green, J.; Boland, E.; Weber, R.P.; Randolph, C.; Bann, C.; Coker-Schwimmer, E.; Viswanathan, M.; Lohr, K.N. (2019). Defining treatment-resistant depression. Depress Anxiety, [Epub ahead of print]: 1-12/DOI: 10.1002/da.22968
Majoie, H. J. M.; van Gaalen, J.; Verstegen, D. M. L.; van Mastrigt, G. A. P. G.; Kleijnen, J.; Alonso-Coello, P.; Gartlehner, G.; Ritchie, K.; Service, D.; Leone, M.; Evers, S. M. A. A. (2019). Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution? European Journal of Neurology, 26: 10.1111/ene.13855
Matyas, N.; Keser Aschenberger, F.; Wagner, G.; Teufer, B.; Auer, S.; Gisinger, C.; Kil, M.; Klerings, I.; Gartlehner, G. (2019). Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review and overview of systematic reviews. BMJ Open, 9: e027719 doi:10.1136/bmjopen-2018-027719
Nussbaumer-Streit, B.; Forneris, C. A.; Morgan, L. C.; Van Noord, M. G.; Gaynes, B. N.; Greenblatt, A.; Wipplinger, J.; Lux, L. J.; Winkler, D.; Gartlehner, G. (2019). Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev, 3: DOI: 10.1002/14651858.CD011269.pub3.
Nussbaumer-Streit, B.; Gartlehner, G. (2019). WHO-Leitlinie: Beratung von Müttern zur Verbesserung von Stillpraktiken. WHO Guideline: Counselling of Women to Improve Breastfeeding Practices. Gesundheitswesen, 01/2020: DOI: 10.1055/a-1068-2420
Nussbaumer-Streit, B.; Greenblatt, A.; Kaminski-Hartenthaler, A.; Van Noord, M.G.; Forneris, C.A.; Morgan, L.C.; Gaynes, B.N.; Wipplinger, J.; Lux, L.L.; Winkler, D.; Gartlehner, G.; (2019). Melatonin and agomelatine for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews, 6: https://doi.org/10.1002/14651858.CD011271.pub3
Teufer, B.; Sommer, I.; Nussbaumer-Streit, B.; Titscher, V.; Bruckmann, C.; Klerings, I.; Gartlehner, G. (2019). Screening for periodontal diseases by non-dental health professionals: a protocol for a systematic review and overview of reviews. Systematic Reviews, 8: 10.1186/s13643-019-0977-9
Van den Nest, M.; Glechner, A.; Gold, M.; Gartlehner, G.; (2019). The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review. Systematic Reviews, 8:321: https://doi.org/10.1186/s13643-019-1235-x
Wagner, G.; Haumer, M.; Poelzl, G.; Wiedemann, D.; Kliegel, A.; Ullrich, R.; Gartlehner, G.; Zuckermann, A.; Müller, L.; Mayr, H.; Moertl, D. (2019). A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation. BMC Cardiovascular Disorders, 19: Article number: 302
Wagner, G.; Steiner, S.; Gartlehner, G.; Arfsten, H.; Wildner, B.; Mayr, H.; Moertl, D. (2019). Comparison of transcatheter aortic valve implantation with other approaches to treat aortic valve stenosis: a systematic review and meta-analysis. Systematic Reviews, 8: 10.1186/s13643-019-0954-3
Kallenbach, M.; Conrad, S.; Hoffmann, F.; Matthias, K.; Gartlehner, G.; Langer, G.; Meerpohl, J. (2019). GRADE: Evidence-to-Decision-Tabellen für die Übernahme, Anpassung und De-novo-Entwicklung von vertrauenswürdigen Empfehlungen: GRADE-ADOLOPMENT. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 144-145, August 2019: 90-99
Lectures (Extract Research Database)
The accuracy of single- vs. dual-reviewer abstract screening: a crowd-based randomized controlled trial.
21. Jahrestagung EbM-Netzwerk 2020, 14/02/2020
Point-of-care Ultrasonography for Acute Dyspnea. A Systematic Review and Meta-analysis.
Meeting of the American College of Physicians Guideline Panel, Philadelphia, USA, 29/01/2020
"Evidence-based Medicine can harm your health" - Cochrane Austria's battle against fake health news.
Herbstseminar d. Wiener Biometrischen Sektion: "Update in Evidence Synthesis Methods - Current Topics in Meta-analysis", Medical University Vienna, Ö., 13/11/2019
Screening for hypertension in children and adolescents.
Meeting of the United States Preventive Services Task Force, Bethesda, USA, 30/10/2019
VU 2020 Empfehlungen des ExpertInnengremiums
Hauptverband der österreichischen Sozialversicherungsträger, Sitzung der leitenden ÄrztInnen, Wien, Österreich, 25/07/2019
Does the pill against lovesickness work? Responding to inquiries from the general public with existing evidence
Evidence Live, Oxford, UK, 15/07/2019
Evidence-based Decision Making
Workshop beim 5th Congress of the European Academy of Neurology, Oslo, Norway, 28/06/2019
Assessing the accuracy of machine-assisted abstract screening with DistillerAI.
Agency for Healthcare Research and Quality EPC V Panel Meeting, Rockville, MD, USA, 07/06/2019
Evidence-based Medicine - ein kritischer Diskurs
Jahrestagung der Österreichischen Akademie für Dermatologische Fortbildung, Graz, Österreich, 30/05/2019
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Webpräsentation; Idaho P&T Committee Meeting, 19/04/2019
Interessenskonflikte bei ÄrztInnen: Wie die Industrie ärztliche Entscheidungen beeinflusst
Sceptics in the Pub, Wien, Österreich, 20/03/2019
Interessenskonflikte bei Ärztinnen und Ärzten: Wie die Industrie medizinische Entscheidungen beeinflusst.
GÖG Symposium, Wien, Österreich, 27/02/2019
VU2020: Methoden der Überarbeitung
VORSORGEUNTERSUCHUNG. Ergebnisse des Evidenz-Updates, Wien Österreich, 30/01/2019
Formulating Questions, Selecting Outcomes and Introduction to the Guideline Development Tool
GRADE Workshop, World Health Organisation, Genf, Schweiz, 10/01/2019
MSc in Public Health - Comparative Effectiveness Research. Module 10: CER Case Studies
Universite Paris Descartes, Paris, Frankreich , 10/12/2018
Interessenskonflikte: Wie die Industrie ärztliche Entscheidungen beeinflusst
Verband der leitenden Krankenhausärzte Österreichs, Kunsthistorisches Museum, Wien, Österreich, 28/11/2018
Interessenskonflikte bei Ärzten: Wie die Industrie ärztliche Entscheidungen beeinflusst.
Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, Österreich, 26/11/2018
Increased risks of false-positive or false-negative findings are common in outcomes graded as high certainty of evidence
25th Cochrane Colloquium Edinburgh, Großbritannien, 18/09/2018
How to use the GRADE approach to assess, interpret and present evidence
25th Cochrane Colloquium Edinburgh, Großbritannien, 16/09/2018
Comparative Effectiveness Review on Targeted Immune Modulators-Update 6.
Webpräsentation für Washington State Pharmacy and Therapeutics Committee Meeting, Washington, USA, 20/06/2018
Tags